PROPYLTHIOURACIL Drug Patent Profile
✉ Email this page to a colleague
When do Propylthiouracil patents expire, and what generic alternatives are available?
Propylthiouracil is a drug marketed by Abbott, Actavis Elizabeth, Anabolic, Ani Pharms, Chartwell Molecular, Chartwell Rx, Endo Operations, Halsey, Impax Labs, Lilly, Macleods Pharms Ltd, Quagen, Sun Pharm Industries, Tablicaps, and Watson Labs. and is included in sixteen NDAs.
The generic ingredient in PROPYLTHIOURACIL is propylthiouracil. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the propylthiouracil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Propylthiouracil
A generic version of PROPYLTHIOURACIL was approved as propylthiouracil by QUAGEN on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROPYLTHIOURACIL?
- What are the global sales for PROPYLTHIOURACIL?
- What is Average Wholesale Price for PROPYLTHIOURACIL?
Summary for PROPYLTHIOURACIL
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 16 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 146 |
| Clinical Trials: | 12 |
| Patent Applications: | 4,860 |
| Drug Prices: | Drug price information for PROPYLTHIOURACIL |
| What excipients (inactive ingredients) are in PROPYLTHIOURACIL? | PROPYLTHIOURACIL excipients list |
| DailyMed Link: | PROPYLTHIOURACIL at DailyMed |
Recent Clinical Trials for PROPYLTHIOURACIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Case Comprehensive Cancer Center | Phase 2 |
| Maastricht University | Phase 2 |
| Maastricht University | Phase 1 |
Pharmacology for PROPYLTHIOURACIL
| Drug Class | Thyroid Hormone Synthesis Inhibitor |
| Mechanism of Action | Thyroid Hormone Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for PROPYLTHIOURACIL
Anatomical Therapeutic Chemical (ATC) Classes for PROPYLTHIOURACIL
US Patents and Regulatory Information for PROPYLTHIOURACIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 084075-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 006188-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ani Pharms | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 080215-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
